EE153 Cost-Minimization of Oral Valganciclovir Vs Intravenous Ganciclovir for Cytomegalovirus Prophylaxis in Renal Transplant Recipients

Autor:	Alves, Junior JM, Prota, FE, Martinelli, JCB, Chrispim, A, Christoforo, FF, Serpeloni, M, Barreto, I, da Silva AC
Zdroj:	In Value in Health June 2024 27(6) Supplement:S85-S85
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect